The relationship between intrinsic thymidylate synthase expression and sensitivity to THYMITAQTM in human leukaemia and colorectal carcinoma cell lines
1997

Thymidylate Synthase Expression and Sensitivity to THYMITAQTM in Cancer Cell Lines

Sample size: 13 publication Evidence: moderate

Author Information

Author(s): EJ Estlin, K Balmanno, AH Calvert, AG Hall, J Lunec, DR Newell, ADJ Pearson, GA Taylor

Primary Institution: University of Newcastle upon Tyne

Hypothesis

The study investigates the relationship between thymidylate synthase expression and sensitivity to THYMITAQTM in human leukaemia and colorectal carcinoma cell lines.

Conclusion

The study found that sensitivity to THYMITAQTM did not correlate with thymidylate synthase activity, protein, or mRNA levels in the tested cell lines.

Supporting Evidence

  • A 20-fold variation in sensitivity to THYMITAQTM was found within the colorectal cell line panel.
  • TS activity was linearly related to TS protein levels (r2 = 0.87, P < 0.0001).
  • Two colorectal cell lines and one leukaemic cell line were intrinsically resistant to THYMITAQTM.

Takeaway

This study looked at how a specific drug affects cancer cells and found that the amount of a certain protein in the cells didn't predict how well the drug would work.

Methodology

The study measured thymidylate synthase activity, protein levels, and mRNA in various cancer cell lines and assessed their sensitivity to THYMITAQTM.

Limitations

The study did not account for potential mutations in thymidylate synthase that could affect drug sensitivity.

Participant Demographics

The study involved human colorectal carcinoma and leukaemia cell lines.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.0001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication